Furthermore, the broad implications of PCSK9 modulation across various physiological and pathological conditions suggest promising therapeutic applications for this innovative ferritin‐based nanoparticle beyond cardiovascular disorders, extending its potential impact to diverse medical fields such as liver and infectious diseases, cancer, and autoimmune disorders. This evidence concerns the gene PCSK9 and cancer.